Efficacy Of Proinflammatory Cytokines in The Primary Molar Pulpotomy

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 5, 2021

Primary Completion Date

November 5, 2022

Study Completion Date

May 17, 2023

Conditions
Pulp Disease, Dental
Interventions
PROCEDURE

PULPOTOMY TREATMENT

During pulpotomy treatment, a bleeding sample was taken from the pulp and levels of presepsin, IL-6 and IL-8, which are important inflammation markers, were determined. During the treatment, MTA, Neo MTA, Biodentine and ZOE groups were randomly selected and the remaining pulp tissue was covered. After pulpotomy treatment, the teeth were followed for one year. Treatment success was evaluated according to the material used in teeth with high levels of inflammation at the beginning.

Trial Locations (1)

25240

Ataturk University Faculty of Dentistry, Yakutiye

All Listed Sponsors
lead

Ataturk University

OTHER

NCT06398327 - Efficacy Of Proinflammatory Cytokines in The Primary Molar Pulpotomy | Biotech Hunter | Biotech Hunter